These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32845785)

  • 21. [Hepatic stellate cells: it's role in normal and pathological conditions].
    Sarem M; Znaidak R; Macías M; Rey R
    Gastroenterol Hepatol; 2006 Feb; 29(2):93-101. PubMed ID: 16448612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection.
    Giannelli G; Antonaci S
    Histol Histopathol; 2005 Jul; 20(3):939-44. PubMed ID: 15944944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential.
    Kong D; Zhang F; Zhang Z; Lu Y; Zheng S
    Biomed Pharmacother; 2013 Apr; 67(3):246-50. PubMed ID: 23201010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
    Bárcena C; Stefanovic M; Tutusaus A; Joannas L; Menéndez A; García-Ruiz C; Sancho-Bru P; Marí M; Caballeria J; Rothlin CV; Fernández-Checa JC; de Frutos PG; Morales A
    J Hepatol; 2015 Sep; 63(3):670-8. PubMed ID: 25908269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis.
    Khatun M; Ray RB
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
    Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
    Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of fetuin, a TGFbeta antagonist and pentoxifylline, a cytokine antagonist on hepatic stellate cell function and fibrotic parameters in fibrosis.
    Verma-Gandhu M; Peterson MR; Peterson TC
    Eur J Pharmacol; 2007 Oct; 572(2-3):220-7. PubMed ID: 17678645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver fibrosis - mouse models and relevance in human liver diseases.
    Mederacke I
    Z Gastroenterol; 2013 Jan; 51(1):55-62. PubMed ID: 23315652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis.
    Amiot L; Vu N; Rauch M; L'Helgoualc'h A; Chalmel F; Gascan H; Turlin B; Guyader D; Samson M
    J Hepatol; 2014 Feb; 60(2):245-52. PubMed ID: 24036009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular basis of hepatic fibrosis and its role in inflammation and cancer.
    Kocabayoglu P; Friedman SL
    Front Biosci (Schol Ed); 2013 Jan; 5(1):217-30. PubMed ID: 23277047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
    Zhang CY; Yuan WG; He P; Lei JH; Wang CX
    World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
    Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
    World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro.
    Zhang Z; Guo Y; Zhang S; Zhang Y; Wang Y; Ni W; Kong D; Chen W; Zheng S
    Eur J Pharmacol; 2013 Dec; 721(1-3):133-40. PubMed ID: 24076327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver fibrosis in alcoholic liver disease.
    Bataller R; Gao B
    Semin Liver Dis; 2015 May; 35(2):146-56. PubMed ID: 25974900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic stellate cells as a target for the treatment of liver fibrosis.
    Bataller R; Brenner DA
    Semin Liver Dis; 2001 Aug; 21(3):437-51. PubMed ID: 11586471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic modifications in hepatic stellate cells contribute to liver fibrosis.
    Zhao Q; Qin CY; Zhao ZH; Fan YC; Wang K
    Tohoku J Exp Med; 2013 Jan; 229(1):35-43. PubMed ID: 23238615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development.
    Ignat SR; Dinescu S; Hermenean A; Costache M
    Cells; 2020 Feb; 9(2):. PubMed ID: 32085494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation.
    Yan Y; Zeng J; Xing L; Li C
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.